Browse Drug Recalls
515 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 515 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 515 FDA drug recalls.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| May 5, 2016 | 16.67 mcg/mL Fentanyl Citrate and 0.1667% Bupivacaine HCl (Preservative Free)... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 10 mcg/mL Fentanyl Citrate and 0.2% Bupivacaine HCl (Preservative Free) in 0.... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 2 mcg/mL Fentanyl Citrate and 0.25% Bupivacaine HCl (Preservative Free) in ... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 2 mcg/mL Fentanyl Citrate and 0.0625% Bupivacaine HCl (Preservative Free) in ... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 20 mcg/mL HYDROmorphone HCl and 0.1% Bupivacaine HCl (Preservative Free) in 0... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 5 mcg/mL Fentanyl Citrate and 0.125% Bupivacaine HCl (Preservative Free) in 0... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 0.15% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 250 mL in ... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 20 mcg/mL Fentanyl Citrate and 0.125% Bupivacaine HCl (Preservative Free) in ... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 3 mcg/mL Fentanyl Citrate and 0.01% Bupivacaine HCl (Preservative Free) in 0.... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 5 mcg/mL Fentanyl Citrate and 0.1% Bupivacaine HCl (Preservative Free) in 0.9... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 0.4 mcg/mL Sufentanil Citrate and 0.0625% Bupivacaine HCl (Preservative Free)... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 5 mcg/mL Fentanyl Citrate and 0.0625% Bupivacaine HCl (Preservative Free) in ... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 10 mcg/mL Fentanyl Citrate and 0.1% Bupivacaine HCl (Preservative Free) in 0.... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 4 mcg/mL Fentanyl Citrate and 0.125% Bupivacaine HCl (Preservative Free) in 0... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 5 mcg/mL HYDROmorphone HCl and 0.125% Bupivacaine HCl (Preservative Free) in ... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 0.05 mg/mL Morphine Sulfate and 0.0625% Bupivacaine HCI (Preservative Free) i... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 10 mcg/mL Fentanyl Citrate and 0.0625% Bupivacaine HCl (Preservative Free) in... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 5 mcg/mL Fentanyl Citrate and 0.04% Bupivacaine HCl (Preservative Free) in 0.... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 6.66 mcg/mL Fentanyl Citrate and 0.22% Bupivacaine HCl (Preservative Free) in... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 2 mcg/mL Fentanyl Citrate and 0.2% Bupivacaine HCl (Preservative Free) in 0.9... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 1 mcg/mL Sufentanil Citrate and 0.1% Bupivacaine HCl (Preservative Free) in 0... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 0.5 mcg/mL Sufentanil Citrate and 0.1% Bupivacaine HCl (Preservative Free) in... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 0.4 mcg/mL Sufentanil Citrate and 0.1% Bupivacaine HCl (Preservative Free) in... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 2 mcg/mL Fentanyl Citrate and 0.125% Bupivacaine HCl (Preservative Free) in 0... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 10 mcg/mL HYDROmorphone HCl and 0.075% Bupivacaine HCl (Preservative Free) in... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| May 5, 2016 | 2 mcg/mL Fentanyl Citrate and 0.16% Bupivacaine HCl (Preservative Free) in 0.... | Presence of Particulate Matter: API contaminated with glass particulate was used to produce steri... | Class II | Pharmedium Services, LLC |
| Apr 25, 2016 | Sensorcaine- MPF (Bupivacaine HCI Injection, USP), 0.75% in a 30 mL Single Do... | Presence of Particulate Matter: Glass particulate found in sterile injectable product | Class II | Fresenius Kabi USA, LLC |
| Apr 7, 2016 | Good Neighbor Pharmacy PEG-Phen Lubricant Eye Drops (Polyethylene Glycol 400 ... | Presence of Particulate Matter | Class II | Akorn, Inc. |
| Mar 23, 2016 | Magnesium Sulfate Inj., USP 50%, 10 g/20 mL (0.5 g/mL), (4 mEq Magnesium/mL, ... | Presence of Particulate Matter: Confirmed customer complaint for the presence of particulate matter. | Class I | Hospira Inc. |
| Mar 18, 2016 | 8.4% Sodium Bicarbonate Injection, USP 50mEq (1mEq/mL), 4.2 grams (84 mg/mL),... | Presence of Particulate Matter: particulate matter identified as an insect in one vial. | Class I | Hospira Inc. |
| Mar 9, 2016 | Amikacin Sulfate injection USP,1 gm/4 mL (250 mg/mL) 4mL vial, Rx only, Manu... | Presence of Particulate Matter: particulate matter identified as glass in one vial. | Class I | Teva Pharmaceuticals USA |
| Feb 16, 2016 | Thyrogen (thyrotropin alfa for injection), 0.9 mg/mL after reconstitution, Fo... | Presence of Particulate Matter: Glass particles found in the product after reconstitution. | Class II | Genzyme Corporation |
| Feb 16, 2016 | Thyrogen (thyrotropin alfa for injection), 0.9 mg/mL after reconstitution, Fo... | Presence of Particulate Matter: Glass particles found in the product after reconstitution. | Class II | Genzyme Corporation |
| Feb 5, 2016 | 0.9% Sodium Chloride Irrigation, USP, 500 mL bottle, Rx Only, Baxter Healthca... | PRESENCE OF PARTICULATE MATTER: Product complaint for the presence of particulate matter identifi... | Class II | Baxter Healthcare Corp. |
| Jan 21, 2016 | CLINIMIX E 5/15 sulfite-free (5% Amino Acid with Electrolytes in 15% Dextrose... | Presence of Particulate Matter: identified as dried skin. | Class I | Baxter Healthcare Corp. |
| Jan 21, 2016 | 0.9% Sodium Chloride Injection USP, MINI-BAG Plus Container, 100 mL VIAFLEX S... | Presence of Particulate Matter: identified as cardboard. | Class I | Baxter Healthcare Corp. |
| Jan 21, 2016 | Metronidazole Injection USP, 500 mg per 100 mL (5 mg/mL), 100mL Sterile Singl... | Presence of Particulate Matter: identified as a cloth fiber. | Class I | Baxter Healthcare Corp. |
| Dec 15, 2015 | Dextrose Injection,USP,70% 2000 mL VIAFLEX Plastic Container Bag, Pharmacy Bu... | Presence of Particulate Matter: Confirmed customer compliants of finding an insect floating in th... | Class I | Baxter Healthcare Corp. |
| Dec 15, 2015 | 0.9% Sodium Chloride Injection, USP, 250 mL VIAFLEX Plastic Container Bag, Rx... | Presence of Particulate Matter: Confirmed customer compliants of finding an insect floating in th... | Class I | Baxter Healthcare Corp. |
| Nov 4, 2015 | Bevacizumab 1.25 mg/0.05 mL filled to 0.06 mL in 3/10 mL 31 G 5/16" Syringe f... | Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes fo... | Class II | Pine Pharmaceuticals, LLC |
| Nov 4, 2015 | Bevacizumab 2.5 mg/0.1 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal inje... | Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes fo... | Class II | Pine Pharmaceuticals, LLC |
| Nov 4, 2015 | Bevacizumab 2 mg/0.08 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal, Rx -... | Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes fo... | Class II | Pine Pharmaceuticals, LLC |
| Nov 4, 2015 | Bevacizumab 1.25 mg/0.05 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal Rx... | Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes fo... | Class II | Pine Pharmaceuticals, LLC |
| Oct 29, 2015 | HYDROCHLOROTHIAZIDE CAPSULES, USP, 12.5 mg, 10 cap/blister, 100-count carton,... | Presence of Particulate Matter | Class II | Amerisource Health Services |
| Oct 7, 2015 | HYDROCHLOROTHIAZIDE CAPSULES, USP, 12.5 mg, 3000 count bottles, Rx only, Manu... | Presence of Particulate Matter. | Class II | Vintage Pharmaceuticals LLC, DBA Qualitest Phar... |
| Aug 25, 2015 | 1% Lidocaine HCl Injection, USP, 10 mg/mL, 30 mL Vial, Single-dose Preservati... | Presence of Particulate Matter: particulate matter identified as iron oxide, was found embedded i... | Class II | Hospira, Inc. |
| Aug 24, 2015 | Refresh P.M. (Mineral Oil 42.5% and White Petrolatum 57.3%) Lubricant Eye Oin... | Presence of Particulate Matter: Due to customer complaints of small black particles, identified a... | Class II | Allergan Sales, LLC |
| Aug 24, 2015 | BLEPHAMIDE (sulfacetamide sodium and prednisolone acetate ophthalmic ointment... | Presence of Particulate Matter: Due to customer complaints of small black particles, identified a... | Class II | Allergan Sales, LLC |
| Aug 24, 2015 | FML (fluorometholone ophthalmic ointment) 0.1%, 3.5 g tube, Rx only, Allergan... | Presence of Particulate Matter: Due to customer complaints of small black particles, identified a... | Class II | Allergan Sales, LLC |
| Aug 24, 2015 | Refresh Lacri-Lube (Mineral Oil 42.5% and White Petrolatum 56.8%) Lubricant E... | Presence of Particulate Matter: Due to customer complaints of small black particles, identified a... | Class II | Allergan Sales, LLC |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.